Literature DB >> 2786884

In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetic models for positron emission tomography.

R E Keen1, J R Barrio, S C Huang, R A Hawkins, M E Phelps.   

Abstract

Leucine oxidation and incorporation into proteins were examined in the in vivo rat brain to determine rates and compartmentation of these processes for the purpose of structuring mathematical compartmental models for the noninvasive estimation of in vivo human cerebral protein synthesis rates (CPSR) using positron emission tomography (PET). Leucine specific activity (SA) in arterial plasma and intracellular free amino acids, leucyl-tRNA, alpha-ketoisocaproic acid (KIC), and protein were determined in whole brain of the adult rat during the first 35 min after intravenous bolus injection of L-[1-14C]leucine. Incorporation of leucine into proteins accounted for 90% of total brain radioactivity at 35 min. The lack of [14C]KIC buildup indicates that leucine oxidation in brain is transaminase limited. Characteristic specific activities were maximal between 0 to 2 min after bolus injection with subsequent decline following the pattern: plasma leucine greater than or equal to leucyl-tRNA approximately KIC greater than intracellular leucine. The time integral of leucine SA in plasma was about four times that of tissue leucine and twice those of leucyl-tRNA and KIC, indicating the existence of free leucine, leucyl-tRNA, and KIC tissue compartments, communicating directly with plasma, and separate secondary free leucine, leucyl-tRNA, and KIC tissue compartments originating in unlabeled leucine from proteolysis. Therefore, a relatively simple model configuration based on the key assumptions that (a) protein incorporation and catabolism proceed from a precursor pool communicating with the plasma space, and (b) leucine catabolism is transaminase limited is justified for the in vivo assessment of CPSR from exogenous leucine sources using PET in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786884     DOI: 10.1038/jcbfm.1989.67

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

Review 1.  Approaches to the design of biochemical probes for positron emission tomography.

Authors:  J R Barrio
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

Review 3.  The measurement of regional rates of cerebral protein synthesis in vivo.

Authors:  C B Smith
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 4.  PET: a biological imaging technique.

Authors:  M E Phelps
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

5.  The effect of elevated plasma phenylalanine levels on protein synthesis rates in adult rat brain.

Authors:  D S Dunlop; X R Yang; A Lajtha
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

6.  Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility.

Authors:  Shrinivas Bishu; Kathleen C Schmidt; Thomas Burlin; Michael Channing; Shielah Conant; Tianjiang Huang; Zhong-hua Liu; Mei Qin; Aaron Unterman; Zengyan Xia; Alan Zametkin; Peter Herscovitch; Carolyn B Smith
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

7.  Use of acute hyperphenylalaninemia in rhesus monkeys to examine sensitivity and stability of the L-[1-11C]leucine method for measurement of regional rates of cerebral protein synthesis with PET.

Authors:  Carolyn B Smith; Kathleen C Schmidt; Shrinivas Bishu; Michael A Channing; Jeff Bacon; Thomas V Burlin; Mei Qin; Zhong-Hua Liu; Zengyan Xia; Tianjiang Huang; Bee-Kee Vuong; Peter Herscovitch
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-23       Impact factor: 6.200

8.  PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.

Authors:  B J Daemen; R Zwertbroek; P H Elsinga; A M Paans; H Doorenbos; W Vaalburg
Journal:  Eur J Nucl Med       Date:  1991
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.